Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 35Breast 5Gastrointestinal 4Gynecologic 2Thoracic 1Plasma cell 1Other solid neoplasm 1Other 1Lymphoid 1Head & Neck 1

Conditions

Motor Activity 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma 11Lymphoma, Follicular 5Leukemia 5Leukemia, Lymphocytic, Chronic, B-Cell 4Breast Neoplasms 4Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Obesity 2Neoplasms 2Hodgkin Disease 2Fatigue 2Cardiotoxicity 2Waldenstrom Macroglobulinemia 1Ventricular Dysfunction, Left 1Urogenital Neoplasms 1Thyroid Neoplasms 1Sarcopenia 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Parasomnias 1Overweight 1Ovarian Neoplasms 1Non-alcoholic Fatty Liver Disease 1Neoplasms, Plasma Cell 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1

Interventions

Vorinostat 3Azacitidine 3venetoclax 2trametinib 2ruxolitinib 2pertuzumab 2palbociclib 2olaparib 2durvalumab 2dabrafenib 2copanlisib 2aflibercept 2abiraterone 2Sunitinib 2Specimen Handling 2Sirolimus 2Nivolumab 2Immunoglobulin G 2HhAntag691 2Doxorubicin 2Disulfides 2Dasatinib 2Cyclophosphamide 2Biopsy 2Afatinib 2Ado-Trastuzumab Emtansine 22C4 antibody 2ulixertinib 1tremelimumab 1trastuzumab biosimilar HLX02 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Exercise × Lymphoid × Clear all
NCT04000880 2025-06-12

AMPLIFY

University of Alabama at Birmingham

Phase NA Active not recruiting
603 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidPlasma cell

Breast Neoplasms, Kidney Neoplasms, Lymphoma, Non-Hodgkin, Motor Activity, Multiple Myeloma, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡